Global Pulmonary Drug Delivery Devices Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2017 to 2025

  • ID: 4431620
  • Report
  • Region: Global
  • Acute Market Reports
1 of 4

FEATURED COMPANIES

  • AstraZeneca plc
  • Boehringer Ingelheim GmbH
  • F. Hoffmann-La Roche Ltd.
  • GlaxoSmithKline plc
  • MannKind Corporation
  • Merck & Co., Inc.
  • MORE
Pulmonary Drug Delivery Devices Market - Growth, Share, Opportunities, Competitive Analysis, and Forecast, 2017 - 2025, the Pulmonary Drug Delivery Devices market was valued at USD 134.6 Bn in 2016, and is expected to reach USD 218.6 Bn by 2025, expanding at a CAGR of 5.4% from 2017 to 2025.

Market Insights

Increasing demand for noninvasive drug administration for respiratory diseases through pulmonary route is expected to boost the market of such devices. According to market experts the efficiency of pulmonary drug delivery devices is high because lungs possess ability to provide large absorptive surface area (up to 100 m2 ) but extremely thin (0.1 µm - 0.2 µm) absorptive mucosal membrane and ample blood supply. Recent advances have developed the overall technology and formulation for pulmonary drug delivery devices. However, pulmonary delivery of peptides and proteins is still complicated due to the anatomic structure of human respiratory system and the effect of nature applied by the respiration process. The key factors responsible for growth of pulmonary drug delivery devices are rising prevalence of respiratory diseases, increasing air pollution in developed and developing countries, high public awareness associated with early diagnosis of respiratory diseases, and incessant research and development activities in the field of drug delivery.

In year 2016, metered dose inhalers accounted for the largest market share in pulmonary drug devices market due to key drivers rising prevalence of asthma and COPD across the globe, high patient convenience, the products and technology has penetrated in market over these years, and observed as the most preferred technology by physicians. During the forecast period 2017 - 2025, dry powder inhalers were anticipated as the fastest growing segment due to key driving factors such as short administration and preparation time, fewer irritant effects and control of inhaled dose, and API protection. A few major brands available in dry powder inhalers category are Spiriva, Atrovent, Foradil, Rotahaler, and FlowCaps among others.

The major application of pulmonary drug delivery devices is into asthma and COPD, in year 2016 asthma accounted for the largest market share due to rising prevalence of asthma, most preferred mode of treatment in asthma, and increasing public awareness related to respiratory diseases. According to World Health Organization (WHO), it is estimated that approximately 334 million people currently suffer from asthma, and 250,000 deaths are attributed to the disease each year. The prevalence of the disease is continuing to grow, and the overall prevalence is estimated to increase by 100 million by 2025. Thus, asthma segment is expected to grow during the forecast period 2017 - 2025 and ultimately assist the growth of overall pulmonary drug delivery devices market.

North America was observed as the largest pulmonary drug delivery devices market due to rising prevalence of respiratory diseases, trending patients and physicians preferences for user friendly drug delivery devices, and increasing demand for fast acting & efficient drug delivery technology. The overall developed healthcare infrastructure, high patient awareness associated with respiratory disease management, and incessant research and development activities in the field of pulmonary drug delivery industry. During forecast 2017 - 2025, Asia Pacific was observed as the fastest growing market segment due to developing healthcare infrastructure, mounting economic growth is fueling air pollution, high public awareness related to respiratory diseases and hygiene, and increasing disposable income.

Market Competition Assessment

The pulmonary drug delivery devices market is observed as the most diversified and competitive market comprising large number of players. The market is dominated by several players, depending on their major competencies. The key players in this market are GlaxoSmithKline, Boehringer Ingelheim GmbH, 3M, AstraZeneca plc, Merck & Co., Inc., Novartis AG, Omron Corporation and Sunovion Pharmaceuticals Inc. among others.

Key Market Movements:
  • Rising prevalence of respiratory diseases especially asthma and COPD
  • Increasing industrialization and economic growth is fuelling the air pollution causing rise in asthma and COPD
  • User friendly, fast acting and cost efficient pulmonary drug delivery devices are in demand
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • AstraZeneca plc
  • Boehringer Ingelheim GmbH
  • F. Hoffmann-La Roche Ltd.
  • GlaxoSmithKline plc
  • MannKind Corporation
  • Merck & Co., Inc.
  • MORE
Chapter 1. Preface
1.1. Report Scope and Description
1.2. Research Methodology
1.2.1. Phase I-Secondary Research
1.2.2. Phase II-Primary Research
1.2.3. Phase II-Expert Panel Review
1.2.4. Assumptions
1.2.5. Approach Adopted

Chapter 2. Executive Summary
2.1. Global Pulmonary Drug Delivery Devices Market Portraiture
2.1.1. Global Pulmonary Drug Delivery Devices Market, by Technology, 2016
2.1.2. Global Pulmonary Drug Delivery Devices Market, by Application, 2016
2.1.3. Global Pulmonary Drug Delivery Devices Market, by Geography, 2016

Chapter 3. Pulmonary Drug Delivery Devices Market: Market Dynamics and Future Outlook
3.1. Market Overview
3.2. Respiratory Diseases: Epidemiology
3.3. Brand Analysis & Comparison: Pulmonary Drug Delivery Devices
3.4. Pipeline Introduction: Pulmonary Drug Delivery Devices
3.5. Drivers
3.6. Challenges
3.7. Opportunities
3.8. Porter’s Five Forces Analysis
3.9. Attractive Investment Proposition, by Geography
3.10. Major Agreements, Partnerships and Collaborations
3.11. Competitive Landscape
3.11.1. Competitive Landscape, by Key Players, 2016

Chapter 4. Global Pulmonary Drug Delivery Devices Market, by Technology, 2015 - 2025 (US$ Mn)
4.1. Overview
4.2. Attractive Investment Proposition: Global Pulmonary Drug Delivery Devices Market, by Technology
4.3. Dry Powder Inhalers
4.3.1. Single-dose inhalers
4.3.2. Multi-dose inhalers
4.4. Metered Dose Inhalers
4.4.1. Manually-actuated pressurized inhaler
4.4.2. Breath-actuated pressurized inhaler
4.5. Nebulizers
4.5.1. Jet nebulizers
4.5.2. Ultrasonic wave nebulizers
4.5.3. Vibrating mesh nebulizers

Chapter 5. Global Pulmonary Drug Delivery Devices Market, by Application, 2015 - 2025 (US$ Mn)
5.1. Overview
5.1.1. Attractive Investment Proposition: Global Pulmonary Drug Delivery Devices Market, by Application
5.2. Asthma
5.3. COPD
5.4. Cystic fibrosis
5.5. Diabetes
5.6. Others (allergic rhinitis, tuberculosis, among others)

Chapter 6. Global Pulmonary Drug Delivery Devices Market, by Geography, 2015 - 2025 (US$ Mn)
6.1. Overview
6.2. North America Pulmonary Drug Delivery Devices Market Analysis, 2015 - 2025
6.2.1. North America Pulmonary Drug Delivery Devices Market, by Technology, 2015 - 2025 (US$ Mn)
6.2.2. North America Pulmonary Drug Delivery Devices Market, by Application, 2015 - 2025 (US$ Mn)
6.2.3. North America Pulmonary Drug Delivery Devices Market, by Country, 2015 - 2025 (US$ Mn)
6.2.3.1. U.S.
6.2.3.2. Canada
6.3. Europe Pulmonary Drug Delivery Devices Market Analysis, 2015 - 2025
6.3.1. Europe Pulmonary Drug Delivery Devices Market, by Technology, 2015 - 2025 (US$ Mn)
6.3.2. Europe Pulmonary Drug Delivery Devices Market, by Application, 2015 - 2025 (US$ Mn)
6.3.3. Europe Pulmonary Drug Delivery Devices Market, by Country, 2015 - 2025 (US$ Mn)
6.3.3.1. U.K.
6.3.3.2. Germany
6.3.3.3. France
6.3.3.4. Spain
6.3.3.5. Italy
6.3.3.6. Rest of Europe
6.4. Asia Pacific Pulmonary Drug Delivery Devices Market Analysis, 2015 - 2025
6.4.1. Asia Pacific Pulmonary Drug Delivery Devices Market, by Technology, 2015 - 2025 (US$ Mn)
6.4.2. Asia Pacific Pulmonary Drug Delivery Devices Market, by Application, 2015 - 2025 (US$ Mn)
6.4.3. Asia Pacific Pulmonary Drug Delivery Devices Market, by Country, 2015 - 2025 (US$ Mn)
6.4.3.1. Japan
6.4.3.2. China
6.4.3.3. India
6.4.3.4. Rest of APAC
6.5. Latin America Pulmonary Drug Delivery Devices Market Analysis, 2015 - 2025
6.5.1. Latin America Pulmonary Drug Delivery Devices Market, by Technology, 2015 - 2025 (US$ Mn)
6.5.2. Latin America Pulmonary Drug Delivery Devices Market, by Application, 2015 - 2025 (US$ Mn)
6.5.3. Latin America Pulmonary Drug Delivery Devices Market, by Country, 2015 - 2025 (US$ Mn)
6.5.3.1. Brazil
6.5.3.2. Mexico
6.5.3.3. Rest of Latin America
6.6. Middle East & Africa (MEA) Pulmonary Drug Delivery Devices Market Analysis, 2015 - 2025
6.6.1. MEA Pulmonary Drug Delivery Devices Market, by Technology, 2015 - 2025 (US$ Mn)
6.6.2. MEA Pulmonary Drug Delivery Devices Market, by Application, 2015 - 2025 (US$ Mn)
6.6.3. MEA Pulmonary Drug Delivery Devices Market, by Region, 2015 - 2025 (US$ Mn)
6.6.3.1. UAE
6.6.3.2. Saudi Arabia
6.6.3.3. South Africa
6.6.3.4. Rest of MEA

Chapter 7. Company Profiles
7.1. Boehringer Ingelheim GmbH
7.1.1. Business Description
7.1.2. Financial Information (Subject to data availability)
7.1.3. Product Portfolio
7.1.4. Key Developments
7.2. Novartis AG
7.3. GlaxoSmithKline plc
7.4. AstraZeneca plc
7.5. Teva Pharmaceutical Industries Ltd.
7.6. Merck & Co., Inc.
7.7. MannKind Corporation
7.8. F. Hoffmann-La Roche Ltd.
7.9. Bristol-Myers Squibb Company
7.10. Mylan N.V.
7.11. Omron Corporation
7.12. 3M Healthcare
7.13. Sunovion Pharmaceuticals, Inc.
7.14. Koninklijke Philips N.V.
7.15. Gerresheimer AG
7.16. Bespak
7.17. AptarGroup, Inc.
7.18. SHL Group
7.19. Nypro Healthcare Inc.
7.20. Chiesi Farmaceutici S.p.A.
7.21. Hovione

List of Figures
Fig. 1 Pulmonary Drug Delivery Devices: Market Segmentation
Fig. 2 Global Pulmonary Drug Delivery Devices Market Share, by Technology, 2016 (Value %)
Fig. 3 Global Pulmonary Drug Delivery Devices Market, by Application, 2016 (US$ Mn)
Fig. 4 Global Pulmonary Drug Delivery Devices Market, by Geography, 2016 (Value %)
Fig. 5 Attractive Investment Proposition, by Geography
Fig. 6 Market Competition Landscape, by Key Players, 2016
Fig. 7 Global Unit-Dose Inhalers Market, 2015 - 2025 (US$ Mn)
Fig. 8 Global Multi-Dose Inhalers Market, 2015 - 2025 (US$ Mn)
Fig. 9 Global Manually-Actuated Pressurized Inhaler Market, 2015 - 2025 (US$ Mn)
Fig. 10 Global Breath-Actuated Pressurized Inhaler Market, 2015 - 2025 (US$ Mn)
Fig. 11 Global Jet Nebulizers Market, 2015 - 2025 (US$ Mn)
Fig. 12 Global Ultrasonic Wave Nebulizers Market, 2015 - 2025 (US$ Mn)
Fig. 13 Global Vibrating Mesh Nebulizers Market, 2015 - 2025 (US$ Mn)
Fig. 14 Global Asthma Treatment Market for Pulmonary Drug Delivery Devices, 2015 - 2025 (US$ Mn)
Fig. 15 Global COPD Treatment Market for Pulmonary Drug Delivery Devices, 2015 - 2025 (US$ Mn)
Fig. 16 Global Cystic Fibrosis Treatment Market for Pulmonary Drug Delivery Devices, 2015 - 2025 (US$ Mn)
Fig. 17 Global Diabetes Treatment Market for Pulmonary Drug Delivery Devices, 2015 - 2025 (US$ Mn)
Fig. 18 Global Other Diseases Treatment Market for Pulmonary Drug Delivery Devices, 2015 - 2025 (US$ Mn)
Fig. 19 U.S. Pulmonary Drug Delivery Devices Market, 2015 - 2025 (US$ Mn)
Fig. 20 Canada Pulmonary Drug Delivery Devices Market, 2015 - 2025 (US$ Mn)
Fig. 21 U.K. Pulmonary Drug Delivery Devices Market, 2015 - 2025 (US$ Mn)
Fig. 22 Germany Pulmonary Drug Delivery Devices Market, 2015 - 2025 (US$ Mn)
Fig. 23 France Pulmonary Drug Delivery Devices Market, 2015-2025 (US$ Mn)
Fig. 24 Spain Pulmonary Drug Delivery Devices Market, 2015-2025 (US$ Mn)
Fig. 25 Italy Pulmonary Drug Delivery Devices Market, 2015-2025 (US$ Mn)
Fig. 26 Rest of Europe Pulmonary Drug Delivery Devices Market, 2015 - 2025 (US$ Mn)
Fig. 27 Japan Pulmonary Drug Delivery Devices Market, 2015 - 2025 (US$ Mn)
Fig. 28 China Pulmonary Drug Delivery Devices Market, 2015 - 2025 (US$ Mn)
Fig. 29 India Pulmonary Drug Delivery Devices Market, 2015 - 2025 (US$ Mn)
Fig. 30 Rest of Asia Pacific Pulmonary Drug Delivery Devices Market, 2015 - 2025 (US$ Mn)
Fig. 31 Brazil Pulmonary Drug Delivery Devices Market, 2015 - 2025 (US$ Mn)
Fig. 32 Mexico Pulmonary Drug Delivery Devices Market, 2015 - 2025 (US$ Mn)
Fig. 33 Rest of Latin America Pulmonary Drug Delivery Devices Market, 2015 - 2025 (US$ Mn)
Fig. 34 UAE Pulmonary Drug Delivery Devices Market, 2015 - 2025 (US$ Mn)
Fig. 35 Saudi Arabia Pulmonary Drug Delivery Devices Market, 2015 - 2025 (US$ Mn)
Fig. 36 South Africa Pulmonary Drug Delivery Devices Market, 2015 - 2025 (US$ Mn)
Fig. 37 Rest of Middle East and Africa Pulmonary Drug Delivery Devices Market, 2015 - 2025 (US$ Mn)

List of Tables
Table 1 Global Pulmonary Drug Delivery Devices Market, by Technology, 2015 - 2025 (US$ Mn)
Table 2 Global Dry Powder Inhalers Market, by Type, 2015 - 2025 (US$ Mn)
Table 3 Global Metered Dose Inhalers Market, by Type, 2015 - 2025 (US$ Mn)
Table 4 Global Nebulizers Market, by Type, 2015 - 2025 (US$ Mn)
Table 5 Global Pulmonary Drug Delivery Devices Market, by Application, 2015 - 2025 (US$ Mn)
Table 6 Global Pulmonary Drug Delivery Devices Market, by Geography, 2015 - 2025 (US$ Mn)
Table 7 North America Pulmonary Drug Delivery Devices Market, by Technology, 2015 - 2025 (US$ Mn)
Table 8 North America Pulmonary Drug Delivery Devices Market, by Application, 2015 - 2025 (US$ Mn)
Table 9 North America Pulmonary Drug Delivery Devices Market, by Country, 2015 - 2025 (US$ Mn)
Table 10 Europe Pulmonary Drug Delivery Devices Market, by Technology, 2015 - 2025 (US$ Mn)
Table 11 Europe Pulmonary Drug Delivery Devices Market, by Application, 2015 - 2025 (US$ Mn)
Table 12 Europe Pulmonary Drug Delivery Devices Market, by Country, 2015 - 2025 (US$ Mn)
Table 13 Asia Pacific Pulmonary Drug Delivery Devices Market, by Technology, 2015 - 2025 (US$ Mn)
Table 14 Asia Pacific Pulmonary Drug Delivery Devices Market, by Application, 2015 - 2025 (US$ Mn)
Table 15 Asia Pacific Pulmonary Drug Delivery Devices Market, by Country, 2015 - 2025 (US$ Mn)
Table 16 Latin America Pulmonary Drug Delivery Devices Market, by Technology, 2015 - 2025 (US$ Mn)
Table 17 Latin America Pulmonary Drug Delivery Devices Market, by Application, 2015 - 2025 (US$ Mn)
Table 18 Latin America Pulmonary Drug Delivery Devices Market, by Country, 2015 - 2025 (US$ Mn)
Table 19 Middle East and Africa Pulmonary Drug Delivery Devices Market, by Technology, 2015 - 2025 (US$ Mn)
Table 20 Middle East and Africa Pulmonary Drug Delivery Devices Market, by Application, 2015 - 2025 (US$ Mn)
Table 21 Middle East and Africa Pulmonary Drug Delivery Devices Market, by Region, 2015 - 2025 (US$ Mn)
Table 22 Boehringer Ingelheim GmbH: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
Table 23 Novartis AG: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
Table 24 GlaxoSmithKline plc: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
Table 25 AstraZeneca plc: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
Table 26 Teva Pharmaceutical Industries Ltd.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
Table 27 Merck & Co., Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
Table 28 MannKind Corporation: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
Table 29 F. Hoffmann-La Roche Ltd.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
Table 30 Bristol-Myers Squibb Company: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
Table 31 Mylan N.V.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
Table 32 Omron Corporation: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
Table 33 3M Healthcare: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
Table 34 Sunovion Pharmaceuticals, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
Table 35 Koninklijke Philips N.V.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
Table 36 Gerresheimer AG: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
Table 37 Bespak: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
Table 38 AptarGroup, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
Table 39 SHL Group: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
Table 40 Nypro Healthcare Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
Table 41 Chiesi Farmaceutici S.p.A.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
Table 42 Hovione: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Boehringer Ingelheim GmbH
  • Novartis AG
  • GlaxoSmithKline plc
  • AstraZeneca plc
  • Teva Pharmaceutical Industries Ltd.
  • Merck & Co., Inc.
  • MannKind Corporation
  • F. Hoffmann-La Roche Ltd.
  • Bristol-Myers Squibb Company
  • Mylan N.V.
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll